Taken together, our findings provide the experimental evidence regarding the clinical significance and biological role of MAPK8IP1P2 in lymphatic metastasis of thyroid cancer, suggesting that MAPK8IP1P2 may be used as a potential biomarker to predict lymphatic metastasis in thyroid cancer patients. The gene discussed is MAPK8IP1P2; the disease is thyroid gland carcinoma.